Key Takeaways
- Credo Technology Group reported Q1 FY2027 revenue of $479.0 million, up 114.7% year over year and 9.6% sequentially, with non-GAAP diluted EPS of $1.20 and non-GAAP gross margin of 68.0%.
- The quarter beat published consensus estimates, and Q2 revenue guidance of $525 million to $535 million was also above the pre-earnings analyst consensus cited by Investor’s Business Daily. The post-earnings selloff therefore reflects an expectations and valuation reset more than a weak-guidance event.
- AECs remain Credo’s largest current business and drove more than 90% of the year-over-year revenue increase, while management said optics is now the fastest-growing business and reiterated more than $600 million of FY2027 optical revenue.
- The most important execution test is the second half: management’s greater-than-85% full-year growth outlook implies more than $1.46 billion of H2 revenue, or more than $730 million per quarter on average, based on company-reported figures and Q2 guidance midpoint.
- At the latest verified September 11, 2026 close of $162.95, CRDO still embeds a premium growth valuation. The investment case increasingly depends on optical diversification, sustained high margins, supply execution and reduced customer concentration.
1. Core Earnings Breakdown
Revenue and Profitability Analysis
Credo delivered Q1 FY2027 revenue of $479.0 million for the quarter ended August 1, 2026, representing 114.7% year-over-year growth and 9.6% sequential growth. GAAP gross margin was 64.5%, while non-GAAP gross margin was 68.0%. GAAP operating income was $120.7 million, equivalent to a 25.2% operating margin, and non-GAAP operating income was $230.6 million, equivalent to a 48.2% operating margin. GAAP diluted EPS was $0.67 and non-GAAP diluted EPS was $1.20. Non-GAAP net income reached $236.3 million, producing a 49.3% non-GAAP net margin.
One disclosure constraint matters before discussing product mix: Credo reports one reportable segment and does not disclose exact quarterly revenue percentages for AECs, optical products and retimers. Any precise product-mix percentage presented as a Q1 fact would therefore be unsupported. The most useful company-reported product evidence is the following:
- AECs: Credo’s Form 10-Q states that increased AEC unit shipments contributed more than 90% of the $255.9 million year-over-year increase in total revenue. Management also described AECs as its largest business, with continued penetration at existing hyperscalers, new customers and higher data rates. Investment view: the current earnings base is still anchored by AEC scale, so the core franchise remains healthy even as the narrative shifts toward optics.
- Optics: Management said optics is the fastest-growing business. Optical DSP revenue reached a record in Q1, Credo recognized its first silicon-photonics PIC revenue after the DustPhotonics acquisition, and first 1.6T DSP revenue remains targeted for later in FY2027. Management reiterated more than $600 million of FY2027 optical revenue, with ZeroFlap Optics, silicon-photonics PICs and optical DSPs each expected to exceed $100 million. Investment view: optics is becoming the second major growth engine that can reduce dependence on AECs and expand content per AI link.
- Retimers: The retimer business also posted record revenue, led by Screaming Eagle at 100G per lane and initial contribution from Blue Heron at 200G per lane. Investment view: retimers give Credo another path into scale-up architectures and broaden its exposure beyond a single physical medium or protocol.
- OmniConnect and Active LED Cables: Management continues to target initial revenue in FY2028 rather than Q1 FY2027. Investment view: these products should be treated as pipeline optionality, not as current-quarter earnings support; their value is in expanding Credo’s addressable content around GPU memory fan-out and longer-reach low-power connectivity.
The profitability picture is stronger than the GAAP headline suggests but not flawless. GAAP gross margin fell to 64.5% from 68.2% in Q4, with acquired-intangible amortization a major factor; non-GAAP gross margin moved only from 68.3% to 68.0%. The more important operating issue was spending: Q1 non-GAAP operating expenses were $95.2 million, above the prior $86 million to $90 million guidance range, because Credo accelerated R&D investment. Even so, non-GAAP operating margin remained an unusually high 48.2% for a company growing revenue at triple-digit rates.
Expectations vs. Actual Results
- Revenue: $479.0 million actual versus $473.3 million consensus cited by Investor’s Business Daily — ✅ Beat by $5.7 million, or approximately 1.2%.
- Non-GAAP diluted EPS: $1.20 actual versus $1.17 consensus — ✅ Beat by $0.03, or approximately 2.6%.
- Non-GAAP operating margin: 48.2% actual versus approximately 49.3% implied by Credo’s prior Q1 guidance midpoints — ⚠️ roughly 110 basis points below the implied midpoint. This is not a published Street operating-margin consensus. The calculation uses the prior company guide: $470 million revenue midpoint × 68% non-GAAP gross-margin midpoint = $319.6 million gross profit; less $88 million non-GAAP operating-expense midpoint = $231.6 million operating income; $231.6 million ÷ $470 million = approximately 49.3%.
The beat was therefore real but not broad-based enough to clear an exceptionally high market bar. Revenue exceeded the top end of Credo’s own prior $465 million to $475 million range, and gross margin landed at the midpoint of guidance. However, non-GAAP operating expenses overshot the prior range by $5.2 million at the high end, which absorbed some of the incremental revenue benefit. In practical terms, the quarter showed excellent demand and operating leverage, but not an upside surprise large enough to justify every assumption embedded in the pre-earnings valuation.
For Q2 FY2027, Credo guided revenue to $525 million to $535 million, GAAP gross margin to 62.9% to 64.9%, non-GAAP gross margin to 67.0% to 69.0%, GAAP operating expenses to $199 million to $204 million, and non-GAAP operating expenses to $100 million to $105 million. The $530 million revenue midpoint was above the approximately $519.8 million pre-earnings analyst estimate cited by Investor’s Business Daily. On the call, management also maintained a greater-than-85% FY2027 revenue-growth outlook, expected non-GAAP gross margin to remain broadly consistent with FY2026, projected non-GAAP operating-expense growth of approximately 55%, and said non-GAAP net margin should be in the vicinity of 50%.
What does the market care about most now? Less about a three-cent EPS beat, and more about whether optical products can create a durable second revenue engine without breaking Credo’s margin structure. The hierarchy of importance is increasingly: optical and AEC product ramps, second-half revenue conversion, gross-margin durability, customer diversification, and then headline EPS. Pipeline matters as well, especially NPO, OmniConnect and Active LED Cables, but investors should distinguish FY2028 design-win optionality from FY2027 reported revenue.
The share-price reaction makes that distinction clear. CRDO fell 8.65% in the September 1 regular session before the earnings release, then dropped another 20.04% on September 2 to $165.22. From the August 31 close of $226.19 through September 2, the two-session decline was approximately 27.0%. The move was not well explained by weak guidance: Q2 revenue guidance was above consensus and the full-year growth outlook remained very strong. A better explanation is that investors were repricing four risks simultaneously: a premium valuation that demanded a larger beat, a visible second-half execution burden, continued customer concentration, and higher spending plus acquisition-related accounting effects. DustPhotonics also required $769.6 million of cash consideration within a $1.251 billion total purchase consideration and introduced acquired-intangible amortization, but immediate M&A dilution appears secondary to the valuation and execution reset.
Earnings Call Highlights
“Verified management takeaway: Credo remains on track for more than $600 million of FY2027 optical revenue, with ZeroFlap Optics, silicon-photonics PICs and optical DSPs each expected above $100 million.”
💡 Reading Between the Lines: Management is deliberately reframing Credo from an AEC-led company into a dual-engine copper-and-optical connectivity platform. If all three optical categories scale simultaneously, the multiple can be supported by a broader revenue base; if one slips, the second-half growth math becomes much harder.
“Verified management takeaway: FY2027 revenue is still expected to grow more than 85%, with a second-half inflection, broadly stable non-GAAP gross margin and non-GAAP net margin near 50%.”
💡 Reading Between the Lines: Credo is signaling that growth should outpace operating investment by a wide margin. The valuation model therefore depends not only on top-line acceleration but also on preserving semiconductor-like gross margins as more complete optical systems enter the mix.
“Verified management takeaway: Credo has been leaning into supply-chain capacity for 18 to 24 months and believes it can support materially higher second-half volumes.”
💡 Reading Between the Lines: The inventory and working-capital build is intentional preparation for demand rather than a passive accumulation. That is a constructive demand signal, but it raises the cost of any schedule slip because inventory, deposits and purchase commitments are being committed ahead of the revenue ramp.
“Verified management takeaway: PILOT uses link-level telemetry to identify deteriorating link integrity, improve cluster bring-up and build a dataset that can inform future product optimization.”
💡 Reading Between the Lines: Credo is trying to move the competitive discussion from raw SerDes performance to system reliability and observability. A software-and-telemetry layer can increase switching costs, strengthen customer qualification advantages and potentially support higher ASPs than commodity connectivity components.
“Verified management takeaway: OmniConnect and Active LED Cables remain targeted for initial FY2028 revenue, while management sees the potential for thousands of dollars of OmniConnect content per GPU.”
💡 Reading Between the Lines: These products are not needed to justify Q1 FY2027 results, but they expand the long-term model beyond network links into memory fan-out and new physical media. Investors should value them as option value until production ramps and customer economics are demonstrated.
2. Deep Business Insights
Hidden Metrics That Matter
Metric 1 — the second-half revenue burden. This is calculated from company-reported figures. Credo generated $1.335116 billion of FY2026 revenue and guided to more than 85% FY2027 growth. The minimum implied FY2027 revenue is therefore $1.335116 billion × 1.85 = more than $2.469965 billion. Using Q1 actual revenue of $479.003 million and the Q2 guidance midpoint of $530 million, required H2 revenue is more than $2.469965 billion − $479.003 million − $530 million = more than $1.460962 billion. Dividing by two implies more than $730.5 million of average quarterly revenue in H2, which is more than 37.8% above the Q2 midpoint. This is the single clearest numerical reason investors are focused on execution rather than the Q1 beat.
Metric 2 — inventory is rising faster than revenue. This is calculated from company-reported figures. Inventory increased from $250.831 million at the end of Q4 to $313.051 million at the end of Q1: ($313.051 million − $250.831 million) ÷ $250.831 million = 24.8% sequential growth. Revenue increased 9.6% sequentially over the same quarter. The gap is consistent with management’s statement that Credo is leaning into the supply chain ahead of H2 ramps. Bullishly, that supports the credibility of expected volume acceleration; bearishly, it increases working-capital and inventory risk if customer deployment schedules move right.
Why do customers choose Credo? The differentiation is not simply a faster chip. Credo combines proprietary SerDes and DSP technology with complete AEC systems, optical DSPs, silicon-photonics PICs, retimers, firmware, manufacturing test, system qualification and PILOT diagnostics. After DustPhotonics, the optical stack extends further into the transceiver, giving Credo more control over power, signal integrity, yield, diagnostics and cost. The company also sells through a two-pronged model: it engages both end users such as hyperscalers and the OEMs, ODMs, contract manufacturers and optical-module suppliers that serve them. Credo’s 10-Q states that this approach has made it a preferred vendor for some customers that then require suppliers to use Credo solutions. That pull-through dynamic is strategically important because it can make a component design win behave more like a system qualification moat.
Industry Chain Reactions
- ✅ Benefit — Taiwan Semiconductor Manufacturing Company, ticker TSM: Credo disclosed that it exclusively used TSMC for semiconductor wafer production in FY2026. If Credo delivers its greater-than-85% FY2027 growth target and ramps additional optical DSP, retimer and SerDes volumes, TSMC is a logical upstream beneficiary. The effect should not be assumed to scale one-for-one with Credo revenue because product mix, process nodes and wafer economics differ.
- ❌ Face Pressure — Astera Labs, ticker ALAB: Astera Labs and Credo both identify each other within the competitive landscape for AI connectivity, particularly around retimers and broader system connectivity. Credo’s record retimer revenue, 100G-per-lane Screaming Eagle deployments and early 200G-per-lane Blue Heron contribution increase competitive overlap. This does not prove share loss at Astera Labs, but it raises the competitive bar for performance, protocol breadth, software integration and hyperscaler qualification.
Valuation Framework and Key Risks
The latest verified CRDO close available at the time of writing was $162.95 on September 11, 2026. Using approximately 187.95 million shares outstanding, that implies an equity value of roughly $30.6 billion. Against the minimum FY2027 revenue implied by management’s greater-than-85% growth outlook of more than $2.47 billion, CRDO trades at roughly 12.4 times that revenue floor. A simple cash-adjusted proxy using the Q1 cash and short-term investment balance of $764.3 million produces an enterprise-value proxy of roughly $29.9 billion, or just under 12.1 times the same minimum revenue figure. These are calculated valuation illustrations, not company-reported valuation multiples.
That is no longer the extreme valuation seen before the earnings reset, but it is still a premium multiple that assumes Credo’s growth remains exceptional. The bull case is straightforward: the greater-than-85% growth floor proves conservative, optics becomes a durable second engine, AEC continues growing from a large base, retimers gain scale-up share, and non-GAAP gross margin stays near the high-60% range. Under that outcome, revenue diversification and roughly 50% non-GAAP net-margin potential can support a structurally higher valuation than a conventional connectivity chip supplier.
The principal risks are equally clear:
- Second-half execution risk: the implied H2 quarterly run rate is dramatically above Q2 guidance and depends on multiple optical ramps arriving on schedule.
- Customer concentration risk: Credo disclosed that its four largest end customers represented 33%, 28%, 13% and 10% of Q1 revenue, or 84% combined. A deployment delay at one hyperscaler can materially move a quarter.
- Margin and mix risk: non-GAAP gross margin remains strong, but complete optical systems may carry different economics than high-margin silicon. GAAP margin also now carries acquired-intangible amortization from DustPhotonics.
- Working-capital and supply risk: inventory rose 24.8% sequentially, and Credo is committing capital ahead of the H2 ramp. This is useful if demand converts on time and painful if it does not.
- Acquisition integration risk: DustPhotonics cost $1.251 billion of total consideration, and goodwill on Credo’s balance sheet increased to $986.4 million. The strategic logic is stronger vertical integration, but the company now has to prove that PIC, DSP, firmware and system integration produce better economics and customer wins than a looser component model.
- Competitive risk: Broadcom, Marvell, Astera Labs and optical-module suppliers all compete across parts of the stack. Credo’s advantage must remain system-level reliability and rapid innovation rather than relying solely on an early product lead.
- Trade and tariff risk: management explicitly said Q2 expectations are based on the current tariff regime, which remains fluid.
The valuation conclusion is therefore nuanced. CRDO’s post-earnings decline materially reduced the amount of perfection priced into the stock, but the current multiple still requires the H2 ramp to arrive and optical diversification to become visible in reported results. The key debate is no longer whether Credo has demand; the company has already demonstrated extraordinary demand. The debate is whether it can convert that demand at the speed implied by its full-year outlook while preserving margins and reducing the concentration risk that comes with hyperscaler-scale deployments.
3. Key FAQs
Did CRDO beat Q1 2027 earnings estimates?
Yes. Credo reported Q1 FY2027 revenue of $479.0 million and non-GAAP diluted EPS of $1.20. Investor’s Business Daily cited consensus estimates of $473.3 million of revenue and $1.17 of adjusted EPS, implying a revenue beat of about 1.2% and an EPS beat of about 2.6%. Credo also exceeded the top end of its own prior revenue guidance range of $465 million to $475 million.
Why did CRDO stock fall after Q1 2027 earnings?
The decline was not primarily caused by weak revenue guidance. Q2 revenue guidance of $525 million to $535 million was above the pre-earnings consensus cited by Investor’s Business Daily. The more credible explanation is that CRDO entered the print with a very high valuation and an unusually high expectations bar, while Q1 non-GAAP operating expenses exceeded prior guidance, customer concentration remained high, GAAP margins absorbed acquisition amortization, and the greater-than-85% FY2027 growth outlook requires a steep H2 revenue ramp. The stock fell 20.04% on September 2 after the release.
What is Credo’s Q2 2027 guidance and FY2027 growth outlook?
For Q2 FY2027, Credo guided to $525 million to $535 million of revenue, 62.9% to 64.9% GAAP gross margin, 67.0% to 69.0% non-GAAP gross margin, $199 million to $204 million of GAAP operating expenses, and $100 million to $105 million of non-GAAP operating expenses. On the earnings call, management said it still expects more than 85% full-year revenue growth, more than $600 million of optical revenue, non-GAAP gross margin broadly consistent with FY2026, approximately 55% non-GAAP operating-expense growth and non-GAAP net margin in the vicinity of 50%.
Primary company sources: Credo’s official Q1 FY2027 earnings release, Credo’s official Q1 FY2027 earnings-call webcast page, and the Q1 FY2027 Form 10-Q filed with the SEC. Credo’s Investor Relations site provides the official webcast/replay but does not publish a text transcript page; management-call wording was cross-checked against the published earnings-call transcript. Consensus comparisons were checked against Investor’s Business Daily, and the September 11 closing price was verified from CRDO historical market data.
For additional company filings and updates, visit Credo Technology Group Investor Relations.
Disclaimer: This article/chart is for educational and informational purposes only and does not constitute investment advice of any kind. Past performance is not indicative of future results. Investors should independently evaluate their own risks.